HOPE 100 is a long-term vision looking forward to 2023, the 100th anniversary of the founding of subsidiary KYORIN Pharmaceutical Co., Ltd. It encompasses our powerful goal of supporting healthy lifestyles through our business in the treatment and prevention of disease and the maintenance and promotion of good health. Our long-term vision HOPE 100 embodies the Group’s corporate philosophy and sets out the Group’s future development objectives. This philosophy is the statement of our business objective and the basic rationale for the Group’s business. The future of the Group is expressed in the statement, “The Kyorin Group will promote diversified business expansion and development of the consumer healthcare business, and by 2023 be recognized both within and outside the Group as a company that supports sound and healthy lifestyles.”Guided by this vision, the Group will spread its business risks and aim to achieve sound, stable, sustainable growth.